Sanjay Lakhotia

Sanjay Lakhotia

Corporate Officer/Principal chez ZENITH CAPITAL CORP.

Fortune : 4 866 $ au 31/01/2026

Health Technology
Consumer Services

Profil

Sanjay Lakhotia is currently Chief Business Officer at Zenith Capital Corp.
(Alberta) since 2014.
Former positions include Associate Director-Corporate Development at MedImmune LLC, Director-Corporate Development at Onyx Pharmaceuticals, Inc., Senior Director-Corporate Development at Portola Pharmaceuticals LLC, Process Development Engineer at Wyeth Pharmaceuticals LLC, and Vice President-Corporate Development at both Pathway Therapeutics, Inc. and Pathway Therapeutics Ltd. Education includes a doctorate from Northwestern University, an MBA from The University of North Carolina at Charlotte, and an undergraduate degree from the University of California.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 48 656 ( 0,03% ) 4 866 $ 31/01/2026

Postes actifs de Sanjay Lakhotia

SociétésPosteDébut
ZENITH CAPITAL CORP. Corporate Officer/Principal 01/08/2014

Anciens postes connus de Sanjay Lakhotia

SociétésPosteFin
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
PORTOLA PHARMACEUTICALS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Sanjay Lakhotia

Formation de Sanjay Lakhotia

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

8

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

  1. Bourse
  2. Insiders
  3. Sanjay Lakhotia